INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 16, 2018 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 1,176 | -- | 483,601 |
| Aug 22, 2018 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 3,211 | -- | 484,777 |
| Dec 19, 2017 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 242,150 | -- | 486,820 |
| Feb 23, 2021 |
Director
Trans History: 742
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 248,079 | $52.03 | 487,088 |
| Aug 03, 2018 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 101,187 | -- | 487,141 |
| Aug 21, 2018 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 847 | -- | 487,988 |
| Dec 13, 2018 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 125,000 | $16.80 | 488,014 |
| May 12, 2020 |
Director, President & CEO
Trans History: 422
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 19,984 | $572.47 | 493,465 |
| May 20, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 77,309 | $30.63 | 497,063 |
| Mar 11, 2020 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 500,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.